首页 | 本学科首页   官方微博 | 高级检索  
检索        

恶性淋巴瘤的治疗进展
引用本文:李小蜂,唐超生.恶性淋巴瘤的治疗进展[J].华夏医学,2002,15(1):119-121.
作者姓名:李小蜂  唐超生
作者单位:桂林市人民医院,广西,桂林,541002
摘    要:综合疗法是治疗恶性淋巴瘤的原则,无论是霍奇金病(HD)或非霍金淋巴瘤(NHL),目前多主张以全身化疗为主,放化疗结合,并强调化疗的剂量强度,难治性及复发性NHL则主张大剂量多药联合化疗,此外,骨髓移植及外周干细胞移植,为部分具有不良因素,恶性程度高者创造了治疗机会,免疫疗法对肿瘤细胞特异性强,副作用小,越来越受到人们关注。

关 键 词:霍奇金病  非霍奇金淋巴瘤  化疗  恶性淋巴瘤  综合疗法  免疫疗法
文章编号:1008-2409(2002)01-0119-03
修稿时间:2001年9月28日

Progress on Treatment of Malignant Lymphoma
LI Xiao feng//The People's Hospital of Guilin,Guilin ,China.Progress on Treatment of Malignant Lymphoma[J].Acta Medicinae Sinica,2002,15(1):119-121.
Authors:LI Xiao feng//The People's Hospital of Guilin  Guilin  China
Institution:LI Xiao feng//The People's Hospital of Guilin,Guilin 541002,China
Abstract:The combination therapy is the principle for the treatment of malignant lymphoma. At present, the whole body chemotherapy is the main method for Hodgkin's disease and non Hodgkin's Lymphoma. The radiotherapy is also used as an assistant method. For the refractory and recurrent non Hodgkin's lymphoma, the large doses and several kinds of drugs are used in clinical practice. Besides that, the usage of bone marrow and blood steam cell transplantation imply the treatment chance for the patients who have the high malignant type. The immunotherapy has the features of specific and light side effect. Recenty, this method is in focus.
Keywords:lymphoma  Hodgkin's disease  non  kodgkin's lymphoma  chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号